Renash Tablet 80 mg contains Resmetirom, a selective thyroid hormone receptor beta (THR-β) agonist used in the management of metabolic dysfunction–associated steatohepatitis (MASH), also known as nonalcoholic steatohepatitis (NASH). It helps reduce liver fat accumulation, improve lipid metabolism, and slow the progression of liver fibrosis in patients with fatty liver disease. This higher-strength formulation is used when greater therapeutic response is required under specialist supervision.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Composition
Indications
Renash Tablet is indicated for:
-
Metabolic dysfunction–associated steatohepatitis (MASH/NASH) with fibrosis (F2–F3)
-
Nonalcoholic fatty liver disease (NAFLD) with metabolic risk factors (as prescribed)
-
Hepatic steatosis with dyslipidemia
-
Adjunct therapy in patients with metabolic liver disorders
Mechanism of Action
Resmetirom selectively activates thyroid hormone receptor beta (THR-β), predominantly expressed in the liver. This enhances hepatic lipid metabolism, increases fatty acid oxidation, and reduces intrahepatic fat accumulation. It also improves serum lipid profiles, including lowering LDL cholesterol, while minimizing systemic thyroid-related side effects due to receptor selectivity.
Dosage and Administration
-
Taken once daily or as directed by a physician.
-
Can be taken with or without food.
-
Dose should be individualized based on liver status and clinical response.
-
Regular monitoring of liver function tests and lipid profile is recommended.
Benefits
-
Reduces liver fat content effectively
-
Helps slow progression of NASH-related fibrosis
-
Improves liver enzyme levels
-
Supports healthy lipid metabolism
-
May reduce cardiovascular risk associated with fatty liver disease
Side Effects
Renash Tablet may cause:
-
Diarrhea
-
Nausea
-
Abdominal discomfort
-
Pruritus (itching)
-
Fatigue
-
Mild elevation in liver enzymes (rare)
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Precautions and Warnings
-
Use only under specialist supervision.
-
Regular monitoring of liver function is required.
-
Caution in patients with gallbladder disease.
-
Not recommended in severe hepatic impairment unless advised.
-
Inform physician about all ongoing medications and thyroid disorders.
Storage
-
Store below 30°C
-
Protect from moisture and light
-
Keep out of reach of children.